Manufacturer record
Caplet India Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Caplet India Pvt. Ltd (West Bengal) were declared Not of Standard Quality between July 2020 and October 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Caplet India Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ambroxol Hydrochloride Solution 100 ml | AML3035Mfg 2023-07 · Exp 2025-06 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2023 |
| Dispersible Amoxycillin Tablets I.P. 125 mg | AXT 11072Mfg 2021-12 · Exp 2023-11 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Aug 2022 |
| Pantoprazole Tablets I.P. 40 mg | PNT94087Mfg 2019-09 · Exp 2021-08 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.